Theileria equi has a biphasic life cycle in horses, with a period of intraleukocyte development followed by patent erythrocytic parasitemia that causes acute and sometimes fatal hemolytic disease. Unlike Theileria spp. that infect cattle (Theileria parva and Theileria annulata), the intraleukocyte stage (schizont) of Theileria equi does not cause uncontrolled host cell proliferation or other significant pathology. Nevertheless, schizont-infected leukocytes are of interest because of their potential to alter host cell function and because immune responses directed against this stage could halt infection and prevent disease. Based on cellular morphology, Theileria equi has been reported to infect lymphocytes in vivo and in vitro, but the specific phenotype of schizont-infected cells has yet to be defined. To resolve this knowledge gap in Theileria equi pathogenesis, peripheral blood mononuclear cells were infected in vitro and the phenotype of infected cells determined using flow cytometry and immunofluorescence microscopy. These experiments demonstrated that the host cell range of Theileria equi was broader than initially reported and included B lymphocytes, T lymphocytes and monocyte/macrophages. To determine if B and T lymphocytes were required to establish infection in vivo, horses affected with severe combined immunodeficiency (SCID), which lack functional B and T lymphocytes, were inoculated with Theileria equi sporozoites. SCID horses developed patent erythrocytic parasitemia, indicating that B and T lymphocytes are not necessary to complete the Theileria equi life cycle in vivo. These findings suggest that the factors mediating Theileria equi leukocyte invasion and intracytoplasmic differentiation are common to several leukocyte subsets and are less restricted than for Theileria annulata and Theileria parva. These data will greatly facilitate future investigation into the relationships between Theileria equi leukocyte tropism and pathogenesis, breed susceptibility, and strain virulence.
Citation: Ramsay JD, Ueti MW, Johnson WC, Scoles GA, Knowles DP, Mealey RH (2013) Lymphocytes and Macrophages Are Infected by Theileria equi, but T Cells and B Cells Are Not Required to Establish Infection In Vivo. PLoS ONE 8(10): e76996. doi:10.1371/journal.pone.0076996
Editor: Ulrike Gertrud Munderloh, University of Minnesota, United States of America
Received: June 26, 2013; Accepted: September 4, 2013; Published: October 7, 2013
This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.
Funding: This project was supported by the Grayson-Jockey Club Research Foundation (www.grayson-jockeyclub.org), the Agriculture and Food Research Initiative Competitive Grant No. 2012-67011-19946 from the USDA National Institute of Food and Agriculture (www.nifa.usda.gov), and USDA-ARS CRIS 5348-32000-028D (www.ars.usda.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Theileria equi is a tick-transmitted apicomplexan hemoprotozoan parasite that causes acute hemolytic disease (equine piroplasmosis) and persistent infection of wild and domestic equids throughout the world , . The life cycle of Theileria equi is biphasic in the mammalian host, with a period of intraleukocyte development (pre-erythrocytic schizogony) followed by patent erythrocytic parasitemia , . The pre-erythrocytic stage of T. equi has not been associated with clinical disease in equids and relatively little work has been done to characterize host-parasite interaction during this phase of infection. In vitro and in vivo, tick-transmitted T. equi sporozoites infect mononuclear leukocytes and differentiate into multinucleated schizonts (schizogony), which further divide to form erythroinvasive merozoites . Based on morphology, schizont-infected cells have been characterized as lymphocytes, but this finding has not been confirmed , . Conversely, the leukocyte tropism is very well described for two close relatives of T. equi, Theileria annulata and Theileria parva . The aforementioned Theileria spp. are bovine pathogens that infect both leukocytes and erythrocytes; however, unlike T. equi, the diseases caused by T. annulata (Tropical Theileriosis) and T. parva (East Coast Fever) are largely due to the transformation and dissemination schizont-infected leukocytes and lymphoproliferation –.
In vivo, T. annulata sporozoites invade macrophages, and to a lesser extent B lymphocytes –, and differentiate into macroschizonts that alter the host cell transcriptome to induce proliferation, dissemination, and modify gene expression –. Native Bos indicus cattle (Sahiwal) are significantly more resistant to Tropical Theileriosis than are Bos taurus cattle (Holstein) due to their ability to regulate the inflammatory response and limit the dissemination of infected cells –. Broad transcriptome analysis of uninfected and infected Holstein and Sahiwal macrophages identified significant differences in the expression of genes related to inflammation and immune responses, suggesting that the relative resistance of Sahiwal cattle is due to an inherent difference in how the host cell functions following infection , . This demonstrates how the tropism of T. annulata for macrophages directly impacts the variation in virulence and pathogenesis observed in these two breeds. The specific phenotype of host cells infected by T. parva (predominantly T lymphocytes in vivo , , –) is of similar importance in East Coast fever. For example, the virulent Muguga strain sporozoites preferentially infecting CD4+ T lymphocytes and the less virulent Chitongo strain only infect and transform CD8+ T cells .
Prior to this study, the phenotype of T. equi-infected leukocytes had only been defined based on cellular morphology, which limits the ability to make meaningful comparisons with other Theileria spp., identify correlates with other phenotypic traits (virulence), and investigate how this stage of infection impacts host immunity. Based on the observations of morphologic studies it could be hypothesized that B and T lymphocytes are required to establish infection with T. equi sporozoites . This hypothesis was specifically tested in the current study by: 1) immunophenotyping schizont-infected cells in vitro with flow cytometry and immunofluorescence antibody microscopy (IFA), and 2) attempting to establish infection in young Arabian horses (foals) with severe combined immunodeficiency (SCID) via sporozoite inoculation. Horses affected with SCID lack functional B and T lymphocytes due to a frameshift mutation in the catalytic subunit of DNA-dependent protein kinase (DNA-PKcs), which results in a complete absence of mature B and T lymphocytes –. Establishing infection in SCID foals with T. equi sporozoites would therefore demonstrate whether or not B and T lymphocytes are necessary in the life cycle of T. equi within the vertebrate host.
Materials and Methods
All animal experiments were carried out in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institute of Health and in conformance with the United States Department of Agriculture animal research guidelines, under a protocol approved by the Washington State University Institutional Animal Care and Use Committee.
Two SCID foals (SCID1 and SCID2), one immunocompetent Arabian foal (Foal1), and 14 adult immunocompetent Arabian or Arabian/pony mixed breed horses (HS1-6, HT1-4, HM1, H1-3; S = sporozoite inoculated, T = tick-transmitted, and M = merozoite inoculated) were used in this study. Foals were approximately one month old at the beginning of the experimental period and all other horses ranged from six months to nine years of age. SCID foals were obtained by selective breeding of Arabian horses (or Arabian/pony crosses) heterozygous for the SCID trait . SCID was initially diagnosed based on persistent lymphopenia and subsequently confirmed by identifying the homozygous mutation in the DNA-PKcs gene sequence , , . SCID foals were maintained as described previously –.
Tick-transmission, sporozoite isolation, cryopreservation, and IV inoculation
Adult male R. microplus ticks were reared and infected with the T. equi Florida strain for tick-transmission as previously described . Briefly, approximately 20,000 larvae were fed on a Holstein calf for 14 days at which time engorged nymphs were forcibly removed and allowed to molt to the adult stage in an incubator for three days at 26°C, at 94% relative humidity and a 12-h photoperiod. To acquire T. equi infection, 500 adult male R. microplus ticks were allowed to feed under a cloth patch for 8 days on horse HM1 during acute infection. HM1 was infected prior to acquisition feeding by intravenous (IV) inoculation with a Florida strain T. equi merozoite blood stabilate. Following acquisition feeding, adult male ticks were collected and incubated for 3 days at 15°C, at 94% relative humidity, with a 12-h photoperiod. Approximately 200 male ticks survived incubation and were subsequently applied under a cloth patch in groups of 50 and allowed to feed on HT1-4 for 10 days to complete tick-transmission.
To obtain T. equi sporozoites for sporozoite inoculation, salivary gland pairs were dissected from infected R. microplus adult male ticks (tick infection as described above). Prior to beginning IV inoculation experiments, the salivary glands from 5–10 cohort ticks were analyzed to determine the infection rate by extracting genomic DNA and performing quantitative real-time PCR targeting a single copy T. equi EMA-1 gene, as previously described , . Remaining salivary gland pairs were then washed in sterile PBS and crushed in a glass homogenizer to release sporozoites. The homogenate was centrifuged at 300 g for 5 min and the supernatant containing sporozoites was collected. Horses HS1-4 were inoculated IV with ∼1×105–106 T. equi sporozoites (as determined by quantitative real-time PCR). Unused salivary glands from the previous tick rearing were washed in 0.5 ml of complete media (RPMI 1640 supplemented with 10% heat inactivated fetal bovine serum, 200 i.u./ml benzyl penicillin, 200 ug/ml streptomycin sulphate, 50 µg/ml gentamycin and 5×10−5 M 2-mercaptoethanol) and crushed in a glass homogenizer to release sporozoites. The supernatants were divided into 2×106 sporozoite aliquots in 2 ml cryovials and brought up to 1 ml volume, with RPMI and DMSO (final fluid composition: 45% RPMI, 45% complete media, and 10% DMSO). All vials were frozen at −80°C and transferred to liquid nitrogen for later use. Aliquots of cryopreserved sporozoites were rapidly thawed in a 37°C water bath and inoculated IV, undiluted or at a 1∶10 dilution in sterile PBS, in SCID foals and the immunocompetent control animals (Foal1, HS5-6). In the first experimental inoculation, SCID1, Foal1, HS5 and HS6 were inoculated with cryopreserved tick salivary gland homogenates containing ∼1×106 sporozoites. SCID1 was subsequently re-inoculated with ∼4×106 cryopreserved sporozoites and SCID2 was inoculated ∼6×106 cryopreserved sporozoites. All horses from the tick-transmitted and sporozoite inoculated groups were monitored for clinical signs of disease and for parasitemia by quantitative real-time PCR, as previously described .
T. equi-infected cell cultures
Peripheral blood mononuclear cells were isolated from whole blood of six different immunocompetent adult Arabian horses (HS2-4 and H1-3) and cultured in 24 or 96 well culture plates at 1×106 cells and 2×105 cells per well, respectively. Culture wells were subsequently inoculated with ∼0.1–3.0×106 sporozoites of T. equi sporozoites (sporozoite isolation as described above). Cells were sampled for cytospin preparation and Diff-Quick staining to monitor infection by light microscopy. SCID foal PBMC were infected similarly; however, cryopreserved SCID foal PBMC from the previous year were used due to the difficulty of coordinating tick rearing experiments with the availability of SCID foals.
Flow cytometry and IFA
Infected and uninfected immunocompetent PBMC were harvested from culture wells 9–14 DPI and 5×105 cells were surface labeled with one of three equine leukocyte-specific murine monoclonal antibodies (mAb) (Table 1), including anti-IgM (B lymphocyte), anti-CD3 (T lymphocyte), and anti-CD172a (monocyte/macrophage) and secondarily labeled with goat anti-mouse polyclonal antibody conjugated with PE-Cy5.5 (Caltag Laboratories, Burlingame, CA). The cells were then fixed in BD Cytofix/Cytoperm (BD Bioscience, Mountain View, CA, USA) and internally labeled with mAb specific for equine merozoite antigen 1 and 2 (anti-EMA 1/2) or an IgG1 isotype control mAb (ColiS69A) (Table 1). In previous studies we have demonstrated that EMA 1/2 is expressed by sporoblasts/sporozoites in tick salivary glands  and by intraleukocyte schizonts . The anti-EMA 1/2 and isotype control mAb were primarily labeled with Alexa Flour 488 in house as per the manufacturer's protocol (Mouse IgG Labeling Kits, Invitrogen, Carlsbad, CA). A FACSort flow cytometer equipped with a Macintosh computer and Cell Quest software (Becton Dickinson Immunocytometry Systems, San Jose, CA) was used to collect flow cytometry data. Cells not used in flow cytometry were cytospun onto glass slides, dried, and cover slipped with SlowFade Gold antifade reagent with DAPI (Invitrogen) for IFA. IFA images were collected with a Zeiss LCM 510 META laser scanning confocal microscope (Carl Zeiss MicroImaging, Inc., Jena, Germany) using the multi-track feature. Images for control slides and experimental slides were scanned at the same exposure settings. To improve image resolution, the contrast and brightness was slightly altered for all images equally.
PBMC were isolated from whole blood of SCID1, SCID2, and Foal1 for leukocyte phenotyping and to detect intracytoplasmic T. equi antigen ex vivo. The expression of CD3, IgM, CD2, CD8, CD4, and CD172a on SCID and immunocompetent PBMC was assessed by flow cytometry as described above, using the murine anti-equine mAbs (Table 1). All antibodies that labeled greater than 2% of SCID foal PBMC (anti-CD2, anti-CD8, anti-CD4, anti-CD172a) were used to surface label cells prior to performing internal labeling with anti-EMA 1/2 (as described above).
All SCID foals were humanely euthanized on day 4 or 5 of acute parasitemia. At necropsy the following tissues were examined for gross lesions and collected for histopathology: brain, choroid plexus, pinna, skin, heart, lungs, liver, tracheobronchial lymph node, thymus, mediastinal lymph node, liver, hepatic lymph node, splenic lymph node, spleen, stomach, small intestine, adrenal gland, kidney, mesenteric lymph node, peripheral lymph nodes, and bone marrow. All tissues were fixed in 10% neutral buffered formalin for 72 hr, paraffin embedded, sectioned at 5 µm, and stained with Giemsa tissue stain.
Levels of peak parasitemia, days to parasitemia, and days to peak parasitemia were compared using unpaired t-tests with Welch correction for unequal variances when appropriate. All statistical analyses were performed using GraphPad Prism 5.01 (GraphPad Software, San Diego, CA) and a significance level (α) of 0.05.
Intravenous inoculation of Theileria equi sporozoites caused acute infection in immunocompetent horses, comparable to vector transmission
To develop a controlled sporozoite challenge protocol, the course of acute infection caused by intravenous sporozoite inoculation was first compared to that of tick-transmission in immunocompetent horses. Four horses (HS1-4) were inoculated with fresh T. equi-infected tick salivary gland homogenates by intravenous injection, while four additional horses (HT1-4) were infected by tick-transmission. In the sporozoite inoculated group, parasitemia was detectable by real time PCR 9–15 days post inoculation (DPI), with peak parasitemia of 106–107 parasites/ml whole blood occurring 12–19 DPI (Fig. 1A). Parasitemia was first detectable in the tick infected group 10–12 DPI, with peak parasitemia of 106–107 parasites/ml whole blood occurring 14–15 DPI. No significant differences were observed in the levels of peak parasitemia or the number of days to peak parasitemia between the inoculation and tick-transmission groups (Fig. 1B, C). Thus, the course of acute infection caused by intravenous sporozoite inoculation was similar to that of tick-transmission.
A. Course of parasitemia (parasites/ml whole blood) for horses infected with T. equi sporozoite (∼1×105–106) by intravenous inoculation or by tick-transmission was assessed by quantitative real time PCR. Levels of peak parasitemia (B) and days to peak parasitemia (C) between groups were compared using a t test with α = 0.05. DPI, days post inoculation.
T. equi Florida strain sporozoites infected peripheral blood mononuclear cells in vitro
Fresh PBMC from six different immunocompetent horses were infected in vitro with T. equi-infected tick salivary gland homogenates (∼0.1–3.0×106 sporozoites) to characterize leukocyte infection in culture. Infection was first detectable by light microscopy in a subpopulation of PBMC between 3–6 DPI and viable schizont-infected cells could be identified up to 45 DPI (data not shown). In contrast, uninfected control PBMC only survived in culture for 12–15 days (data not shown). Intracellular macroschizonts and extracellular merozoites were detectable by light microscopy between 6-12 DPI (representative photomicrograph, Fig. 2A). Schizont-infected cells were identified by the presence of few to abundant, small (∼0.5 to 1.0 µm), purple, intracytoplasmic parasite nuclei. Schizont-infected cells undergoing mitosis were extremely rare (i.e. approximately one observed in >50 Diff-Quick stained cytospin preparations). Debris from ruptured cells, extracellular merozoites, and extracellular schizonts were commonly identified adjacent to intact cells (Fig. 2A). T. equi infection was confirmed by IFA using anti-EMA 1/2 mAb. The immunoreactivity of intracytoplasmic schizonts varied from multifocal and discrete to diffuse, and was consistent with the morphology and distribution of the parasites observed with light microscopy (Fig. 2B, C, D). Inoculation of erythrocyte cultures with ∼1×106 fresh T. equi sporozoites did not result in infection (data not shown). These findings are consistent with previous reports and demonstrate the capacity of T. equi Florida strain to infect leukocytes , .
T. equi (Florida strain) infected PBMC day 9-11 in culture; Diff-Quick stained, cytospin preparation (A), and IFA (B, C, and D). (A) Schizont-infected cells have few to abundant, ∼0.5–1.0 µm diameter, purple, intracytoplasmic parasite nuclei (arrow). Adjacent to schizont-infected cells there are several extracellular merozoites (asterix), schizonts (arrowhead), and cellular debris. (B, C and D) IFA images of cells containing different schizont forms are labeled with anti-EMA 1/2 (green). (B) Infected cell is surface labeled with anti-IgM mAb (B lymphocyte). (C, D) Infected cells did not express detectable leukocyte specific surface markers. Nuclei are stained blue with DAPI.
T. equi schizont-infected PBMC expressed macrophage, B lymphocyte, or T lymphocyte specific surface markers in vitro
To determine the phenotype of schizont-infected leukocytes, whole PBMC from three immunocompetent horses (H1-3) were infected with T. equi sporozoites in vitro and analyzed by flow cytometry and IFA (Fig. 3). A panel of three mAb [anti-IgM (B lymphocyte), anti-CD3 (T lymphocyte), or anti-CD172a (macrophage)] were used to surface label the cells, and intracellular staining with a second mAb specific for equine merozoite antigen 1 and 2 (anti-EMA 1/2) was used to detect infection. H1 cells were used in a pilot experiment to optimize immunolabling and determine the time point (DPI) when both surface and internal labeling was readily detectable by flow cytometry and IFA (data not shown). Based on the findings of this experiment, phenotyping of H2 and H3 infected cells was performed 10–11 DPI. In H2 and H3 cultures analyzed by flow cytometry, a subset of each leukocyte phenotype was dual labeled with anti-EMA 1/2 (Fig. 3A). Further analysis of each leukocyte sub-population demonstrated that a relatively high proportion of the B lymphocytes (range: 34.5% to 36.8%) and macrophages (range: 31.5% to 31.0%) were infected, as compared to the low proportion of T lymphocytes (range: 4.5% to 8.9%) (Fig. 3A), suggesting that T. equi preferentially infects B lymphocytes and macrophages. Immunofluorescence microscopy verified that the vast majority of dual labeled cells were infected with schizonts; however, there were rare cells that had punctate foci of immunoreactivity with the EMA 1/2 mAb along their outer margin (Fig. 3B, arrow) and the space adjacent to cells multifocally contained scant, irregular to round, immunoreactive debris (Fig. 3B, arrowhead). The presence of this extracellular EMA 1/2+ material is consistent with the extracellular merozoites and schizonts identified by light microscopy (Fig. 2A). Overall, the signal generated by the leukocyte-specific monoclonal antibodies was unevenly distributed and less abundant on infected cells as compared to uninfected cells (Fig. 3B).
Flow cytometric (A) and IFA (B) analysis of schizont-infected cells in vitro. (A) Representative flow cytometric data for infect horse H2. Left column: percent of total PBMC dual labeled with leukocyte specific mAbs and T. equi specific mAb (anti-EMA 1/2). Right column: percent infected cells determined on IgM+ (B lymphocyte), CD3+ (T lymphocyte), or CD172a+ (macrophage) gated leukocytes. (B) IFA images of schizont-infected cells dual-labeled with one of the three leukocyte specific mAb and anti-EMA 1/2. The nuclei of all cells were stained blue with DAPI. The anti-EMA 1/2 mAb either formed diffuse signal throughout the cytoplasm of infected cells or discrete signal along the surface of intracytoplasmic macroschizonts. Rare cells had punctate foci of EMA 1/2+ immunoreactivity along their outer margin (top left panel; arrow). The space adjacent to cells multifocally contained scant, irregular to round, immunoreactive debris (left panels of second and third row; arrowhead). The anti-IgM, anti-CD3, and anti-CD172a mAb formed punctate to diffuse signal along the outer surface of infected cells. Labeling with an isotype control for the anti-EMA 1/2 mAb did not form any detectable signal (representative data shown in the bottom panels of B).
Intravenous sporozoite inoculation of SCID foals caused patent merozoite parasitemia
SCID foals were infected with cryopreserved T. equi sporozoites by intravenous inoculation to determine if B lymphocytes and/or T lymphocytes were required for schizont differentiation in vivo. In the first experimental inoculation, one SCID foal (SCID1), one age-matched immunocompetent foal (Foal1), and two adult horses, were inoculated with cryopreserved tick salivary gland homogenates containing ∼1×106 sporozoites (determined by real-time PCR on a cohort of infected ticks). One of the adult horses and Foal1 developed patent merozoite parasitemia by 9 and 21 DPI, respectively. SCID1 did not become parasitemic and remained PCR negative until the end of the experimental period (28 DPI). The second adult horse similarly remained PCR negative throughout the experimental period (74 DPI), suggesting that after cryopreservation, a dose of 1×106 sporozoites was at the threshold of the infectious dose. To rule out the possibility that the lack of infection in SCID1 was due to innate resistance caused by lymphocyte deficiency, SCID1 was re-inoculated with 4×106 cryopreserved sporozoites and a second SCID foal (SCID2) was inoculated with 6×106 cryopreserved sporozoites. Both SCID1 and SCID2 became PCR positive 13 and 11 DPI, respectively, and developed uncontrolled parasitemia (Fig. 4). These findings demonstrated that horses lacking functional T and B lymphocytes could be infected with T. equi sporozoites. Finally, the course of infection in SCID and normal horses caused by sporozoite inoculation was compared to that of merozoite inoculation performed in previous published ,  and unpublished experiments. This analysis demonstrated that the prepatent period of sporozoite infection was 6–10 days longer than merozoite infection (Fig. 5). This observation was consistent with the time required to complete schizogony in culture and provides additional support for intraleukocyte schizont development in SCID foals.
Course of parasitemia for SCID foals infected with sporozoites by intravenous inoculation. SCID1 = 4×106; SCID2 = 6×106 sporozoites.
Days to first detectable parasitemia for immunocompetent and SCID foals inoculated intravenously with sporozoites was compared with that for historical SCID controls inoculated with merozoite-parasitized erythrocyte stabilates , , using a t test (α = 0.05).
T. equi Florida strain sporozoites infected SCID foal peripheral blood mononuclear cells in vitro
Although it is well known that SCID foals lack B and T lymphocytes –, –, , flow cytometric analysis was performed for confirmation on SCID1 and SCID2 PBMC using a panel of six mAb against equine B lymphocytes (anti-IgM), T lymphocytes (anti-CD3, CD2, CD8, and CD4), and macrophages (anti-CD172a). In both SCID1 and SCID2, less than 1% of the PBMC analyzed were identified as B or T lymphocytes (data not shown). Approximately 5% of PBMC were CD2+/CD3−, consistent with a natural killer (NK) cell phenotype , . A similar proportion of SCID PBMC were CD8+ (∼4%) or CD4+ (∼6%). Given the lack of CD3+ cells, CD8+ and CD4+ cells were interpreted to be NK cells and monocytes/macrophages, respectively. Greater than 90% of the analyzed PBMC were CD172a+, indicating that they were monocytes/macrophages (data not shown). Although the anti-CD172a mAb also identifies equine granulocytes , the ficoll hypaque PBMC isolation protocol (which removes the majority of granulocytes) together with the lack of internal complexity in the labeled cells (data not shown), provided further evidence that they were monocytes/macrophages. Overall, these data confirmed the SCID phenotype and indicated that the establishment of T. equi infection in SCID1 and SCID2 did not involve B or T lymphocytes.
Next, cryopreserved SCID foal PBMC were inoculated with 4×105 fresh T. equi sporozoites in vitro to confirm infection of SCID leukocytes. Prior to cryopreservation of these PBMC, flow cytometric analysis was performed as above which confirmed the same phenotypic distribution of cells, including the lack of B and T lymphocytes (data not shown). On day 6 post inoculation, schizont-infected mononuclear cells were identified by light microscopy in the cultures from both SCID foals (data not shown). Due to the poor survival of cryopreserved SCID PBMC in culture and the paucity of schizont-infected cells, further analysis to determine the phenotype of these schizont-infected cells was not possible.
Persistent leukocyte infection was not detected in SCID foals
To determine if schizont-infected leukocytes persist in the absence of an adaptive immune response, tissue samples and peripheral blood from SCID1 and SCID2 were assessed for the presence of schizont-infected cells. Prior to the termination of the experiment, PBMC were isolated from SCID1 (15 DPI) and immunocompetent Foal1 (48 DPI) and analyzed by flow cytometry as above with the addition of intracellular staining using anti-EMA 1/2 to identify cells containing T. equi antigen (Fig. 6). Monocytes/macrophages were the only cells that contained equine merozoite antigen (EMA). Cytospin preparations of fresh PBMC from SCID1 and SCID2 consisted of abundant histiocytic round cells, with no detectable schizont-infected cells (data not shown). This finding suggested that the antigen detected in monocytes/macrophages by flow cytometry was due to phagocytosis of merozoite infected erythrocytes and not due to persistent schizont infection of monocytes. Postmortem tissue samples were collected from SCID1, SCID2, and Foal1 for histologic examination following Giemsa staining. No schizont-infected cells were identified in any of these tissues from any animal (data not shown).
In previous studies, T. equi schizont-infected cells have been characterized in vitro and ex vivo as lymphocytes based on their microscopic and ultrastructural morphology , , . The subtle differences between lymphocyte and monocyte/macrophage morphology (e.g. amount of cytoplasm, nuclear shape) are, however, distorted by intracytoplasmic schizont development and precludes determining the specific identity of infected cells. The present study was designed to resolve the phenotype of schizont-infected cells in vitro and determine if lymphocytes were required to establish infection in vivo. Flow cytometric analysis of PBMC infected in vitro demonstrated that T. equi infected B lymphocytes, T lymphocytes, and monocyte/macrophages. Subsequent immunefluorescent microscopic analysis confirmed that the vast majority of cells labeled with T. equi antigen specific mAb contained schizonts within their cytoplasm; however, there were rare cells that had small, punctate foci of immunoreactivity with the EMA 1/2 mAb along the outer margin of the cell. Since all cultures examined contained merozoites released from infected leukocytes, it could not be determined if these small foci of immunoreactivity were sporozoites arrested during initial invasion, merozoites attached to the host cell membrane, or simply immunoreactive debris within the culture. Regardless, these findings demonstrate for the first time that the host cell range of T. equi extends to include both lymphocytes and monocyte/macrophages, making it the most promiscuous among related Theileria spp. (T. annulata and T. parva).
The specific host surface molecule(s) recognized and bound by Theileria sporozoites during leukocyte invasion is not defined; however, MHC class I molecules have been shown to be essential for T. parva sporozoite host-cell recognition and binding . The fact that MHC class I molecules are ubiquitously expressed on nucleated cells suggests that other host molecules must also be involved to facilitate a selective and specific interaction. The observation that antibodies reactive with a number of lymphocyte cell surface molecules also block T. parva sporozoite entry supports this hypothesis . The relatively broad host-cell range of T. equi characterized in the present study suggests that the specific molecules recognized by T. equi sporozoites are common to lymphocytes and macrophages; thus, future work to characterize the host cell receptor recognized by T. equi sporozoites should focus on shared molecules.
Interestingly, both T. parva and T. annulata alter the expression of surface and non-surface associated host molecules (e.g. surface immunoglobulin, T cell markers, MHC class I molecules, pro-inflammatory cytokines) , , , –. In the IFA performed in the present study, IgM, CD3, and CD172a labeling was reduced and unevenly distributed on the surface of infected cells as compared to uninfected cells. This finding suggests that T. equi alters the expression of cell surface molecules similar to T. annulata and T. parva; however, additional work is required to more specifically and quantitatively assess the impact T. equi has on the expression of host surface and non-surface associated molecules.
The finding that T. equi leukocyte tropism overlaps with both T. annulata and T. parva is of interest because it suggests that the protective immune responses directed against each of the latter Theileria spp. schizont stages (i.e. CTL and cytostatic macrophages) would also be important for protection against T. equi. It is known that horses infected with T. equi are resistant to disease when they are re-exposed to the parasite , but at present the mechanism of resistance is unknown. Antigens that elicit immune responses directed against the pre-erythrocytic stages of T. equi represent attractive vaccine candidates because they have the potential to control infection prior to the pathogenic and tick-transmissible blood stage. The apparent transient nature of T. equi schizonts suggests that these responses may be more difficult to elicit in the horse; however, Bos indicus cattle infected with T. parva-infected B lymphocyte lines develop a similarly transient and self-limiting schizont parasitosis, but are still protected against lethal challenge .
To evaluate the leukocyte tropism of T. equi in vivo an intravenous sporozoite challenge model was developed to more precisely control the inoculation dose and eliminate potential problems associated with tick-transmission in SCID foals (i.e., secondary bacterial infection at site of tick attachment, unexpected tick mortality during transmission feeding, and physiologic stress caused by feeding ticks on young horses). In immunocompetent horses there was no statistically significant difference between the course of parasitemia caused by tick-transmission versus intravenous sporozoite inoculation. However, the time to peak parasitemia was more variable in the sporozoite inoculated group. Although the cause for this greater variability is not known, it may have been related to a difference in the sporozoite dose provided by a single intravenous inoculation versus that of a ten day tick-transmission. To test hypotheses directly related to infection kinetics in the future, it will be important to determine how dose and other factors (e.g., route of infection) influence the time to peak parasitemia. For the present study, intravenous sporozoite inoculation allowed testing of the stated hypothesis and avoided the aforementioned problems with tick-transmission.
Establishing T. equi infection in two SCID foals by sporozoite inoculation confirmed that the leukocyte tropism of T. equi extends beyond T and B lymphocytes, and also demonstrated the utility of this model for T. equi immunology research. Specifically, SCID foals could be used to study innate immune responses in vivo in the absence of adaptive immunity. Furthermore, it should be possible to directly determine the correlates of protective adaptive immunity against T. equi pre-erythrocytic stages by adoptive transfer of antigen specific T lymphocytes or by passive antibody transfer experiments . Since the phenotype of schizont-infected cells could impact pathogenesis and strain virulence, it would be important to fully characterize the phenotype of schizont-infected SCID leukocytes. Based on the phenotypic analysis performed here, it was concluded that monocyte/macrophages comprised the cell type most likely infected in SCID foals. However, since SCID foals also possess NK cells , , the possibility that NK cells were also infected in vivo cannot be ruled out.
Although the primary reason for performing the SCID foal experiments was to establish the necessity of B and T lymphocytes in T. equi pathogenesis, the secondary goal was to determine whether the absence of adaptive immunity resulted in a prolonged course of leukocyte infection. Since merozoite parasitemia is uncontrolled and rapidly fatal in SCID foals , post-infection flow cytometric analysis could not be performed beyond the acute stage of disease (i.e., 15 DPI). This analysis demonstrated that monocyte/macrophages were the only cells that contained the EMA 1/2 antigen. When these PBMC were examined by light microscopy however, no schizont-infected cells were identified. This suggested that the antigen detected within these cells was due to the phagocytosis of parasitized erythrocytes and not persistent schizont infection. Histologic examination of postmortem tissues similarly failed to identify schizont-infected cells, providing additional evidence that the schizont stage does not persist in vivo. This finding is consistent with the apparent transient nature of the schizont-infected cells in immunocompetent horses and in the cultures of the present study.
In contrast to the results reported here, others have described T. equi schizonts transforming PBMC into lymphoblastoid forms that proliferate for up to 5 months in culture , . Unfortunately, the previously cited studies were largely descriptive and did not report the specific strain of T. equi used; therefore, we cannot provide meaningful speculation regarding the likely reason for these differing results. The lack of leukocyte transformation with the strain of T. equi used herein (Florida strain) is consistent with the genomic analysis of this strain, which did not identify homologs to the putative Theileria host cell transforming genes .
In summary, these data provide for the first time a comprehensive and specific analysis of T. equi leukocyte tropism, and demonstrate that the T. equi host cell range extends beyond lymphocytes. The finding that the T. equi host cell range includes monocytes/macrophages establishes a closer phenotypic relationship with T. annulata, and justifies the investigation of adaptive and innate immune responses that are important against Tropical Theileriosis (e.g. cytostatic macrophages). Importantly, the observation that SCID foals can become infected following inoculation with T. equi pre-erythrocytic stages establishes an in vivo model for dissecting mechanisms of both innate and adaptive of immunity directed against sporozoites and schizonts. Finally, this work provides the basis for future research to determine the mechanism of leukocyte recognition and invasion, characterize the host cell functions altered by parasite infection, and investigating leukocyte tropism as it relates to other phenotypic traits.
We acknowledge the excellent technical assistance of Steve Leib, Ryan Evanoff, Emma Karel, James Allison, Ralph Horn, Abigail Olson, Shauna Harth, Lowell Kappmeyer, and Nancy Kumpula.
Conceived and designed the experiments: JDR MWU WCJ GAS DPK RHM. Performed the experiments: JDR MWU WCJ. Analyzed the data: JDR MWU WCJ GAS DPK RHM. Contributed reagents/materials/analysis tools: JDR MWU GAS DPK RHM. Wrote the paper: JDR RHM.
- 1. Schein E (1988) Equine Babesiosis. In: Ristic M, Babesiosis of Domestic Animals and Man. Boca Raton: CRC Press. 197–208.
- 2. De Waal DT (1992) Equine piroplasmosis: a review. Br Vet J 148: 6–14. doi: 10.1016/0007-1935(92)90061-5
- 3. Mehlhorn H, Schein E (1998) Redescription of Babesia equi Laveran, 1901 as Theileria equi Mehlhorn, Schein 1998. Parasitol Res 84: 467–475. doi: 10.1007/s004360050431
- 4. Schein E, Rehbein G, Voigt WP, Zweygarth E (1981) Babesia equi (Laveran 1901) 1. Development in horses and in lymphocyte culture. Tropenmed Parasitol 32: 223–227.
- 5. Kappmeyer LS, Thiagarajan M, Herndon DR, Ramsay JD, Caler E, et al. (2012) Comparative genomic analysis and phylogenetic position of Theileria equi. BMC Genomics 13: 603. doi: 10.1186/1471-2164-13-603
- 6. Forsyth LM, Minns FC, Kirvar E, Adamson RE, Hall FR, et al. (1999) Tissue damage in cattle infected with Theileria annulata accompanied by metastasis of cytokine-producing, schizont-infected mononuclear phagocytes. J Comp Pathol 120: 39–57. doi: 10.1053/jcpa.1998.0256
- 7. Boulter N, Hall R (1999) Immunity and vaccine development in the bovine theilerioses. Adv Parasitol 44: 41–97. doi: 10.1016/s0065-308x(08)60230-4
- 8. Morrison WI, Buscher G, Murray M, Emery DL, Masake RA, et al. (1981) Theileria parva: kinetics of infection in the lymphoid system of cattle. Exp Parasitol 52: 248–260. doi: 10.1016/0014-4894(81)90080-1
- 9. Barnett SF (1960) Connective tissue reactions in acute fatal East Coast fever (Theileria parva) of cattle. J Infect Dis 107: 253–282. doi: 10.1093/infdis/107.3.253
- 10. Glass EJ, Innes EA, Spooner RL, Brown CG (1989) Infection of bovine monocyte/macrophage populations with Theileria annulata and Theileria parva. Vet Immunol Immunopathol 22: 355–368. doi: 10.1016/0165-2427(89)90171-2
- 11. Spooner RL, Innes EA, Glass EJ, Brown CG (1989) Theileria annulata and T. parva infect and transform different bovine mononuclear cells. Immunology 66: 284–288. doi: 10.1016/0165-2427(89)90171-2
- 12. Campbell JD, Brown DJ, Glass EJ, Hall FR, Spooner RL (1994) Theileria annulata sporozoite targets. Parasite Immunol 16: 501–505. doi: 10.1111/j.1365-3024.1994.tb00378.x
- 13. McGuire K, Manuja A, Russell GC, Springbett A, Craigmile SC, et al. (2004) Quantitative analysis of pro-inflammatory cytokine mRNA expression in Theileria annulata-infected cell lines derived from resistant and susceptible cattle. Vet Immunol Immunopathol 99: 87–98. doi: 10.1016/j.vetimm.2004.01.003
- 14. Jensen K, Paxton E, Waddington D, Talbot R, Darghouth MA, et al. (2008) Differences in the transcriptional responses induced by Theileria annulata infection in bovine monocytes derived from resistant and susceptible cattle breeds. Int J Parasitol 38: 313–325. doi: 10.1016/j.ijpara.2007.08.007
- 15. Glass EJ, Crutchley S, Jensen K (2012) Living with the enemy or uninvited guests: Functional genomics approaches to investigating host resistance or tolerance traits to a protozoan parasite, Theileria annulata, in cattle. Vet Immunol Immunopathol 148: 178–189. doi: 10.1016/j.vetimm.2012.03.006
- 16. Chaussepied M, Janski N, Baumgartner M, Lizundia R, Jensen K, et al. (2010) TGF-b2 induction regulates invasiveness of Theileria-transformed leukocytes and disease susceptibility. PLoS Pathog 6 (11): e1001197 doi:10.1371/journal.ppat.1001197.
- 17. Preston PM, Brown CG, Bell-Sakyi L, Richardson W, Sanderson A (1992) Tropical theileriosis in Bos taurus and Bos taurus cross Bos indicus calves: response to infection with graded doses of sporozoites of Theileria annulata. Res Vet Sci 53: 230–243. doi: 10.1016/0034-5288(92)90115-i
- 18. Glass EJ, Preston PM, Springbett A, Craigmile S, Kirvar E, et al. (2005) Bos taurus and Bos indicus (Sahiwal) calves respond differently to infection with Theileria annulata and produce markedly different levels of acute phase proteins. Int J Parasitol 35: 337–347. doi: 10.1016/j.ijpara.2004.12.006
- 19. Morrison WI, MacHugh ND, Lalor PA (1996) Pathogenicity of Theileria parva is influenced by the host cell type infected by the parasite. Infect Immun 64: 557–562.
- 20. Baldwin CL, Black SJ, Brown WC, Conrad PA, Goddeeris BM, et al. (1988) Bovine T cells, B cells, and null cells are transformed by the protozoan parasite Theileria parva. Infect Immun 56: 462–467.
- 21. Emery DL, MacHugh ND, Morrison WI (1988) Theileria parva (Muguga) infects bovine T-lymphocytes in vivo and induces coexpression of BoT4 and BoT8. Parasite Immunol 10: 379–391. doi: 10.1111/j.1365-3024.1988.tb00228.x
- 22. Tindih HS, Geysen D, Goddeeris BM, Awino E, Dobbelaere DA, et al. (2012) A Theileria parva isolate of low virulence infects a subpopulation of lymphocytes. Infect Immun 80: 1267–1273. doi: 10.1128/iai.05085-11
- 23. Shin EK, Perryman LE, Meek K (1997) A kinase-negative mutation of DNA-PK(CS) in equine SCID results in defective coding and signal joint formation. J Immunol 158: 3565–3569.
- 24. Wiler R, Leber R, Moore BB, VanDyk LF, Perryman LE, et al. (1995) Equine severe combined immunodeficiency: a defect in V(D)J recombination and DNA-dependent protein kinase activity. Proc Natl Acad Sci U S A 92: 11485–11489. doi: 10.1073/pnas.92.25.11485
- 25. McGuire TC, Banks KL, Poppie MJ (1975) Combined immunodeficiency in horses: characterization of the lymphocyte defect. Clin Immunol Immunopathol 3: 555–566. doi: 10.1016/0090-1229(75)90080-x
- 26. Perryman LE, Torbeck RL (1980) Combined immunodeficiency of Arabian horses: confirmation of autosomal recessive mode of inheritance. Journal Of The American Veterinary Medical Association 176: 1250–1251.
- 27. McGuire TC, Poppie MJ, Banks KL (1974) Combined (B- and T-lymphocyte) immunodeficiency: a fatal genetic disease in Arabian foals. Journal Of The American Veterinary Medical Association 164: 70–76.
- 28. Mealey RH, Fraser DG, Oaks JL, Cantor GH, McGuire TC (2001) Immune reconstitution prevents continuous equine infectious anemia virus replication in an arabian foal with severe combined immunodeficiency: lessons for control of lentiviruses. Clin Immunol 101: 237–247. doi: 10.1006/clim.2001.5109
- 29. Mealey RH, Littke MH, Leib SR, Davis WC, McGuire TC (2008) Failure of low-dose recombinant human IL-2 to support the survival of virus-specific CTL clones infused into severe combined immunodeficient foals: Lack of correlation between in vitro activity and in vivo efficacy. Vet Immunol Immunopathol 121: 8–22. doi: 10.1016/j.vetimm.2007.07.011
- 30. Taylor SD, Leib SR, Carpenter S, Mealey RH (2010) Selection of a rare neutralization-resistant variant following passive transfer of convalescent immune plasma in equine infectious anemia virus-challenged SCID horses. J Virol 84: 6536–6548. doi: 10.1128/jvi.00218-10
- 31. Ueti MW, Palmer GH, Scoles GA, Kappmeyer LS, Knowles DP (2008) Persistently infected horses are reservoirs for intrastadial tick-borne transmission of the apicomplexan parasite Babesia equi. Infect Immun 76: 3525–3529. doi: 10.1128/iai.00251-08
- 32. Ueti MW, Palmer GH, Kappmeyer LS, Statdfield M, Scoles GA, et al. (2005) Ability of the vector tick Boophilus microplus to acquire and transmit Babesia equi following feeding on chronically infected horses with low-level parasitemia. J Clin Microbiol 43: 3755–3759. doi: 10.1128/jcm.43.8.3755-3759.2005
- 33. Ueti MW, Palmer GH, Kappmeyer LS, Scoles GA, Knowles DP (2003) Expression of equi merozoite antigen 2 during development of Babesia equi in the midgut and salivary gland of the vector tick Boophilus microplus. J Clin Microbiol 41: 5803–5809. doi: 10.1128/jcm.41.12.5803-5809.2003
- 34. Mehlhorn H, Schein E (1984) The piroplasms: life cycle and sexual stages. Adv Parasitol 23: 37–103. doi: 10.1016/s0065-308x(08)60285-7
- 35. Mealey RH, Kappmeyer LS, Ueti MW, Wagner B, Knowles DP (2012) Protective Effects of Passively Transferred Merozoite-Specific Antibodies against Theileria equi in Horses with Severe Combined Immunodeficiency. Clin Vaccine Immunol 19: 100–104. doi: 10.1128/cvi.05301-11
- 36. Knowles DP Jr, Kappmeyer LS, Perryman LE (1994) Specific immune responses are required to control parasitemia in Babesia equi infection. Infect Immun 62: 1909–1913.
- 37. Perryman LE, McGuire TC (1978) Mixed lymphocyte culture responses in combined immunodeficiency of horses. Transplantation 25: 50–52. doi: 10.1097/00007890-197802000-00002
- 38. Lunn DP, McClure JT, Schobert CS, Holmes MA (1995) Abnormal patterns of equine leucocyte differentiation antigen expression in severe combined immunodeficiency foals suggests the phenotype of normal equine natural killer cells. Immunology 84: 495–499.
- 39. Patton KM, McGuire TC, Fraser DG, Hines SA (2004) Rhodococcus equi-infected macrophages are recognized and killed by CD8+ T lymphocytes in a major histocompatibility complex class I-unrestricted fashion. Infect Immun 72: 7073–7083. doi: 10.1128/iai.72.12.7073-7083.2004
- 40. Ibrahim S, Saunders K, Kydd JH, Lunn DP, Steinbach F (2007) Screening of anti-human leukocyte monoclonal antibodies for reactivity with equine leukocytes. Vet Immunol Immunopathol 119: 63–80. doi: 10.1016/j.vetimm.2007.06.034
- 41. Moltmann UG, Mehlhorn H, Schein E, Rehbein G, Voigt WP, et al. (1983) Fine structure of Babesia equi Laveran, 1901 within lymphocytes and erythrocytes of horses: an in vivo and in vitro study. J Parasitol 69: 111–120. doi: 10.2307/3281285
- 42. Rehbein G, Zweygarth E, Voigt WP, Schein E (1982) Establishment of Babesia equi-infected lymphoblastoid cell lines. Z Parasitenkd 67: 125–127. doi: 10.1007/bf00929521
- 43. Shaw MK, Tilney LG, Musoke AJ, Teale AJ (1995) MHC class I molecules are an essential cell surface component involved in Theileria parva sporozoite binding to bovine lymphocytes. J Cell Sci 108 (Pt 4): 1587–1596.
- 44. Shaw MK (1997) The same but different: the biology of Theileria sporozoite entry into bovine cells. Int J Parasitol 27: 457–474. doi: 10.1016/s0020-7519(97)00015-5
- 45. Oliver RA, Williams JL (1996) Altered expression of class I major histocompatibility antigens on bovine cells infected with the protozoan parasite Theileria annulata. Vet Immunol Immunopathol 50: 173–179. doi: 10.1016/0165-2427(95)05487-1
- 46. Conrad PA, Baldwin CL, Brown WC, Sohanpal B, Dolan TT, et al. (1989) Infection of bovine T cell clones with genotypically distinct Theileria parva parasites and analysis of their cell surface phenotype. Parasitology 99 Pt 2: 205–213. doi: 10.1017/s0031182000058650
- 47. Kinnaird JH, Weir W, Durrani Z, Pillai SS, Baird M, et al. (2013) A Bovine Lymphosarcoma Cell Line Infected with Theileria annulata Exhibits an Irreversible Reconfiguration of Host Cell Gene Expression. PLoS ONE 8 (6): e66833 doi: 10.1371/journal.pone.0066833.
- 48. McGuire TC, Perryman LE, Davis WC (1983) Analysis of serum and lymphocyte surface IgM of healthy and immunodeficient horses with monoclonal antibodies. Am J Vet Res 44: 1284–1288.
- 49. Blanchard-Channell M, Moore PF, Stott JL (1994) Characterization of monoclonal antibodies specific for equine homologues of CD3 and CD5. Immunology 82: 548–554.
- 50. Tumas DB, Brassfield AL, Travenor AS, Hines MT, Davis WC, et al. (1994) Monoclonal antibodies to the equine CD2 T lymphocyte marker, to a pan-granulocyte/monocyte marker and to a unique pan-B lymphocyte marker. Immunobiology 192: 48–64. doi: 10.1016/s0171-2985(11)80407-9
- 51. Kydd J, Antczak DF, Allen WR, Barbis D, Butcher G, et al. (1994) Report of the First International Workshop on Equine Leucocyte Antigens, Cambridge, UK, July 1991. Vet Immunol Immunopathol 42: 3–60. doi: 10.1016/0165-2427(94)90088-4
- 52. Knowles DP, Perryman LE, Goff WL, Miller CD, Harrington RD, et al. (1991) A monoclonal antibody defines a geographically conserved surface protein epitope of Babesia equi merozoites. Infect Immun 59: 2412–2417.
- 53. Cantor GH, Pritchard SM, Dequiedt F, Willems L, Kettmann R, et al. (2001) CD5 is dissociated from the B-cell receptor in B cells from bovine leukemia virus-infected, persistently lymphocytotic cattle: consequences to B-cell receptor-mediated apoptosis. J Virol 75: 1689–1696. doi: 10.1128/jvi.75.4.1689-1696.2001